High Court Grants Novel ‘Dynamic Blocking’ Order to Combat Online Sales of Counterfeit Medicines
On 23 June 2026, the English High Court handed down its decision to grant and extend website blocking orders sought by Novo Nordisk against third-party ISPs to target the online sale of counterfeit prescription-only medicines. Notably, the court has developed a novel “dynamic blocking” mechanism, enabling Novo Nordisk to self-certify any third-party website
